Nurix Therapeutics (NRIX) stock: bexobrutideg’s BTK degradation shows strong efficacy in B-cell cancers, backed by $650M cash ...
Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately ...
Among patients with relapsed or refractory multiple myeloma, Tecvayli (teclistamab-cqyv) monotherapy was associated with a 71 ...
Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...
Alleged Bondi terrorist Naveed Akram is spending a minimum of 16 hours a day locked up alone in a cell behind a steel door at ...
Rob Lantz and Mark Ledwell faced off in the first of three leadership forums Wednesday night in Summerside. Both Lantz and ...
Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.
Johnson & Johnson announces positive results from phase 3 MajesTEC-9 study of Tecvayli in patients with multiple myeloma: Raritan, New Jersey Friday, January 16, 2026, 10:00 Hrs [ ...
Live Science on MSN
'Zombie' cells may drive common form of epilepsy
Scientists are unraveling the role of senescent cells in a common form of epilepsy, and it could point to new treatments.
Detailed price information for Estrella Immunopharma Inc (ESLA-Q) from The Globe and Mail including charting and trades.
Chowhound on MSN
Folic Acid Is Man-Made: Here's Why It's Added To Food
Many staple foods are fortified with folic acid and can lead to many potential health benefits. Here's what to know about ...
With two words, Elon Musk changed the classic methods of revolution forever. “Activate Starlink,” he said in a social media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback